tm
Seeing Is Believing
tm
Seeing Is Believing
CNTX is currently covered by 1 analysts with an average price target of $4.53. This is a potential upside of $3.92 (642.62%) from yesterday's end of day stock price of $0.61.
Context Therapeutics's activity chart (see below) currently has 2 price targets and 10 ratings on display. The stock rating distribution of CNTX is 87.5% BUY and 12.5% HOLD.
Highest price target for CNTX is $6, Lowest price target is $6, average price target is $6.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 23-Sep-2024. First documented stock forecast 02-Feb-2022.
Currently out of the existing stock ratings of CNTX, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$6
$4.99 (494.06%)
$6
8 months 24 days ago
(23-Sep-2024)
0/8 (0%)
$3.92 (188.46%)
What is CNTX (Context Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CNTX (Context Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CNTX (Context Therapeutics)?
Which analyst is the currently most bullish on CNTX (Context Therapeutics)?
